Skip to content
10-Q

Quarterly Report

BIOPLUS LIFE CORP

0001493152-21-000045

← back to feed
Filed
Jan 4, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Oct 12, 2020 362.91M sh
Current Liabilities Q2 2020 · Jun 30, 2020 $786.68K
Current Liabilities Q2 2020 · Dec 31, 2019 $782.81K
Total Liabilities Q2 2020 · Jun 30, 2020 $1.45M
Total Liabilities Q2 2020 · Dec 31, 2019 $1.47M
Current Assets Q2 2020 · Jun 30, 2020 $1.2M
Current Assets Q2 2020 · Dec 31, 2019 $989.71K
Operating Income Q2 2020 · Jun 30, 2020 $170.48K
Operating Income Q2 2020 · Jun 30, 2020 $178.7K
Operating Income Q2 2020 · Jun 30, 2019 $18.93K
Operating Income Q2 2020 · Jun 30, 2019 −$32.89K
Cash And Equivalents Q2 2020 · Dec 31, 2019 $210.74K
Total Assets Q2 2020 · Dec 31, 2019 $3.21M
Capex Q2 2020 · Jun 30, 2019 $13.73K
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$96.22K
Sga Expense Q2 2020 · Jun 30, 2019 $169.81K
Sga Expense Q2 2020 · Jun 30, 2019 $371.23K
Net Income Q2 2020 · Jun 30, 2019 $18.93K
Net Income Q2 2020 · Jun 30, 2019 −$32.89K
Gross Profit Q2 2020 · Jun 30, 2019 $194.91K
Gross Profit Q2 2020 · Jun 30, 2019 $350.9K
Cost Of Revenue Q2 2020 · Jun 30, 2019 $202.05K
Cost Of Revenue Q2 2020 · Jun 30, 2019 $403.99K
Revenue Q2 2020 · Jun 30, 2019 $396.95K
Revenue Q2 2020 · Jun 30, 2019 $754.89K